MRC1 and cancer: Noteworthy, our findings differ from a previous study, in which biallelic inactivation of Mbd4 had no impact on mutation frequency in vivo and did not modify the cancer predisposition phenotype in mice doubly deficient for Mbd4 and MMR genes [33].